Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Moe Oguchi"'
Autor:
Yohei Komaru, Moe Oguchi, Tomohito Sadahiro, Taka-aki Nakada, Noriyuki Hattori, Takeshi Moriguchi, Junko Goto, Hidetoshi Shiga, Yoshihiko Kikuchi, Shigeo Negi, Takashi Shigematsu, Naohide Kuriyama, Tomoyuki Nakamura, Kent Doi
Publikováno v:
Annals of Intensive Care, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Background Patients with severe acute kidney injury (AKI) who require continuous venovenous hemodiafiltration (CVVHDF) in intensive care unit (ICU) are at high mortality risk. Little is known about clinical biomarkers for risk prediction, op
Externí odkaz:
https://doaj.org/article/f6338621fb144bada33a4c3ad3065c28
Autor:
Hiroko Yuzawa, Yousuke Hirose, Tomonori Kimura, Keisuke Shinozaki, Moe Oguchi, Tomohiro Morito, Tomohito Sadahiro
Publikováno v:
Renal Replacement Therapy, Vol 7, Iss 1, Pp 1-8 (2021)
Abstract Background In continuous renal replacement therapy (CRRT), administration of anticoagulants is necessary for achieving a certain level of filter lifetime. Generally, anticoagulant doses are controlled to keep activated partial thromboplastin
Externí odkaz:
https://doaj.org/article/a8d37a1917e7429ab05995d015f493d2
Publikováno v:
Journal of the Japanese Society of Intensive Care Medicine. 28:537-541
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b22aba14a3b95d4565b54d85cdc54ba5
https://doi.org/10.3918/jsicm.28_537
https://doi.org/10.3918/jsicm.28_537
Autor:
Tomohiro Morito, Moe Oguchi, Keisuke Shinozaki, Hiroko Yuzawa, Yousuke Hirose, Tomohito Sadahiro, Tomonori Kimura
Publikováno v:
Renal Replacement Therapy, Vol 7, Iss 1, Pp 1-8 (2021)
Background In continuous renal replacement therapy (CRRT), administration of anticoagulants is necessary for achieving a certain level of filter lifetime. Generally, anticoagulant doses are controlled to keep activated partial thromboplastin time and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37c589a7b246f2f9466b53ecbf0a1fd5
https://doi.org/10.1186/s41100-021-00323-1
https://doi.org/10.1186/s41100-021-00323-1
Autor:
Hiroko Yuzawa, Shohei Mizushima, Tomohiro Morito, Yousuke Hirose, Moe Oguchi, Tomohito Sadahiro, Tomonori Kimura
Publikováno v:
Acute Medicine & Surgery
Direct hemoperfusion was useful for the treatment of phenobarbital poisoning. It decreased the blood levels of phenobarbital and improved the level of consciousness.
Aim Phenobarbital overdose can cause coma and even death. The consciousness dis
Aim Phenobarbital overdose can cause coma and even death. The consciousness dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da58281ac4eea74f4a11480ce9a0fde4
http://europepmc.org/articles/PMC7671091
http://europepmc.org/articles/PMC7671091
Autor:
Nobuya Katayama, Tomonori Kimura, Yuka Osaki, Moe Oguchi, Satomi Nakajima, Kengo Kondo, Tomohiro Morito, Tomohito Sadahiro, Hiroko Yuzawa, Kaori Ishigaki
Publikováno v:
Critical Care Medicine. 48:685-685
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b62ee3b27eda621a5f9529b3d904d7c
https://doi.org/10.1097/01.ccm.0000645584.86684.da
https://doi.org/10.1097/01.ccm.0000645584.86684.da
Autor:
Tomohito, Sadahiro, Hiroko, Yuzawa, Tomonori, Kimura, Moe, Oguchi, Tomohiro, Morito, Shohei, Mizushima, Yousuke, Hirose
Publikováno v:
Contributions to nephrology. 196
Continuous venovenous hemodiafiltration is the modality of choice for acute blood purification therapy at almost all medical institutions in Japan. Nafamostat mesilate, an ultrashort-acting anticoagulant, is widely used for anticoagulation. Due to re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3aa77fa575a9f28c2586439829418e8e
https://pubmed.ncbi.nlm.nih.gov/30041229
https://pubmed.ncbi.nlm.nih.gov/30041229
Autor:
Moe Oguchi, Yousuke Hirose, Tomohito Sadahiro, Tomonori Kimura, Tomohiro Morito, Shohei Mizushima, Hiroko Yuzawa
Continuous venovenous hemodiafiltration is the modality of choice for acute blood purification therapy at almost all medical institutions in Japan. Nafamostat mesilate, an ultrashort-acting anticoagulant, is widely used for anticoagulation. Due to re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c88e7b3d08a4c6eb80d0f660a2580c6d
https://doi.org/10.1159/000485724
https://doi.org/10.1159/000485724
